I spy Dr Noe and Frank Hudson at Agensys
This article was originally published in Scrip
Agensys, a subsidiary of Astellas which is developing a pipeline of therapeutic fully human monoclonal antibodies to treat cancers, has appointed Frank Hudson vice-president of finance, and Dr Wolfgang Noe vice-president of process sciences and manufacturing. Mr Hudson joins Agensys from Mannkind Corporation where he had served as vice-president of finance since 2007. Dr Noe most recently served as vice-president of strategic development and technical alliances at Biogen Idec.